- Organización Mundial de la Salud. Enfermedad por el virus del Ébola. (Consultado el 20 de junio de 2018.) Disponible en: http://www.who.int/es/news-room/fact-sheets/detail/ebola-virus-disease.
- Organización Mundial de la Salud. Se declara un nuevo brote de Ébola en la República Democrática del Congo. Disponible en: http://www.who.int/es/news-room/detail/08-05-2018-new-ebola-outbreak-declared-in-democratic-republic-of-the-congo
- Chertow DS, Kleine C, Edwards JK, Scaini R, Giuliani R, Sprecher A. Ebola virus disease in West Africa — Clinical manifestations and management. N Engl J Med. 2014;371:2054-7.
- CDC. Ebola virus disease. (Consultado el 10 de junio de 2018.) https://www.cdc.gov/vhf/ebola/index.html
- Ministerio de Sanidad, Servicios Sociales e Igualdad. Informe resumen sobre las actuaciones realizadas en España en relación a la epidemia de enfermedad por virus del Ébola. Marzo 2014-enero 2016. MSSSI; 2016. (Consultado el 19 de junio de 2018.) Disponible en: https://www.msssi.gob.es/profesionales/saludPublica/ccayes/alertasActual/ebola/docs/Informe_actuaciones_Espana_14.01.2016.pdf
- Lopaz MA, Amela C, Ordobas M, Domínguez-Berjón MF, Álvarez C, Martínez M, et al. First secondary case of Ebola outside Africa: epidemiological characteristics and contact monitoring, Spain, September to November 2014. Euro Surveill. 2015;20(1). pii: 21003.
- World Health Organization. WHO consultation on Ebola vaccines. WHO; 2014. (Consultado el 19 de septiembre de 2016.) Disponible en: www.who.int/immunization/diseases/ebola/WHO_consultation_ebola_sep2014/en/
- Carter RJ, Idriss A, Widdowson MA, Samai M, Schrag SJ, Legardy-Williams JK, et al. Implementing a multisite clinical trial in the midst of an Ebola outbreak: lessons learned from the Sierra Leone trial to introduce a vaccine against Ebola. J Infect Dis. 2018;217 (Suppl 1):S16-S23.
- Abramowitz SA, Hipgrave DB, Witchard A, Heymann DL. Lessons from the West Africa Ebola epidemic: a systematic review of epidemiological and social and behavioral science research priorities. J Infect Dis. 2018 Jun 23. doi: 10.1093/infdis/jiy387. [Epub ahead of print]
- Kanapathipillai R, Henao Restrepo AM, Fast P, Wood D, Dye C, Kieny MP, et al. Ebola vaccine — an urgent international priority. N Engl J Med. 2014;371:2249-51.
- World Health Organization. Ebola vaccines, therapies, and diagnostics. Questions and answers. WHO; 2015. (Acceso 5 julio 2018). Disponible en: www.who.int/medicines/emp_ebola_q_as/en/
- Henao-Restrepo AM, Longini IM, Egger M, Dean NE, Edmunds WJ, Camacho A, et al. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Lancet. 2015;386:857-66.
- Agnandji ST, Huttner A, Zinser ME, Njuguna P, Dahlke C, Fernandes JF, et al. Phase 1 trials of rVSV Ebola vaccine in Africa and Europe. N Engl J Med. 2016;374:1647-60.
- SAGE Experts Group on EVD Vaccine and Vaccination. Ebola vaccines and vaccination. Report of the SAGE Working Group on Ebola Vaccines and Vaccination with provisional recommendations for vaccination. 2015. (Consultado el 19 de junio de 2018.) Disponible en: http://www.who.int/immunization/sage/meetings/2015/october/2_ WHO_SAGE_WG_ebola_vaccines_and_immunization_MPP_VM_AMHR.pdf
- Henao-Restrepo AM, Camacho A, Longini IM, Watson CH, Edmunds WJ, Egger M, et al. Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!). Lancet. 2017;389:505-18.
- WHO supports Ebola vaccination of high risk populations in the Democratic Republic of the Congo. (Consultado el 5 de julio de 2018.) http://www.who.int/news-room/detail/21-05-2018-who-supports-ebola-vaccination-of-high-riskpopulations-in-the-democratic-republic-of-the-congo
